LG Technology Ventures

RegCell is developing cell therapies for autoimmune disease by epigenetically reprogramming pathogenic conventional T cells into stable regulatory T cells, aiming to restore immune tolerance without gene engineering; its platform is advancing toward clinical development.

AI security and governance platform purpose-built for enterprise AI agents

Helps platform teams and cloud providers modernize and manage infrastructure for the AI era